Effects of niceritrol on levels of serum lipids, lipoprotein(a), and fibrinogen in patients with primary hypercholesterolemia
Abstract
Thirty-three consecutive unselected patients with primary hypercholesterolemia received niceritrol 1.5 g daily for 12 weeks, with the effect of administering divided dose (twice daily (b.i.d.) and three times daily (t.i.d.)) evaluated. The serum concentrations of lipoprotein(a) (Lp(a)), lipids, the major apolipoproteins (apo), cholesteryl ester transfer activity and fibrinogen were determined before and after treatment. The b.i.d. and t.i.d. regimens each significantly reduced the serum levels of total cholesterol and triglyceride. The mean changes in serum lipids and lipoproteins did not differ significantly between the two groups. After 12 weeks of treatment, there was a significant decrease in total plasma cholesterol, triglyceride, low density lipoprotein cholesterol, apo A-II, apo B and fibrinogen and an increase in the high density lipoprotein cholesterol levels. Although the serum level of Lp(a) did not change in every patient, niceritrol significantly reduced the serum Lp(a) level in those with an initially high level of Lp(a) (greater than or equal to 20 mg/dl).
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Nicotinic acid derivatives have Lp(a)-lowering effects.
“Nicotinic acid derivatives also have Lp(a)-lowering effects689–691).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [689]
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · see citing works
Enzymatic determination of total serum cholesterol.
Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond, W., & Fu, P. C. (1974) · Clinical Chemistry · doi:10.1093/clinchem/20.4.470 · Cited by 9,845 · see citing works
Meade, T. W., Brozović, M., Chakrabarti, R., Haines, A., Imeson, J., Mellows, S., Miller, G. J., North, W. R. S., Stirling, Y., & Thompson, S. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90111-x · Cited by 1,937 · see citing works
Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., & Tibblin, G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110804 · Cited by 1,645 · see citing works
Warnick, G. R., & Albers, J. J. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41577-9 · Cited by 1,250 · see citing works
A new method for the determination of fibrinogen in small samples of plasma.
Ratnoff, O. D., & Menzie, C. M. (1951) · PubMed · Cited by 997 · see citing works
Eine neue Bestimmung der Neutralfette im Blutserum und Gewebe
Eggstein, M., & Kreutz, F. H. (1966) · Journal of Molecular Medicine · doi:10.1007/bf01747716 · Cited by 942 · see citing works
Obituary. Rupert Samuel Bruce Pearson.
Dm, O. (1974) · PubMed · Cited by 759 · see citing works
Lipoprotein Lp(a) and the risk for myocardial infarction
Kostner, G. M., Avogaro, P., Cazzolato, G., Marth, E., Bittolo-Bon, G., & Qunici, G. B. (1981) · Atherosclerosis · doi:10.1016/0021-9150(81)90103-9 · Cited by 687 · see citing works
PLASMA LIPID TRANSFER PROTEINS
Tall, A. R. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.001315 · Cited by 639 · see citing works
CARLSON, L. A., HAMSTEN, A., & ASPLUND, A. (1989) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1989.tb01393.x · Cited by 443 · see citing works
Plasma lipid transfer proteins.
Tall, A. R. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38819-2 · Cited by 377 · see citing works
HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.
Kostner, G. M., Gavish, D., Leopold, B., Bolzano, K., Weintraub, M. S., & Breslow, J. L. (1989) · Circulation · doi:10.1161/01.cir.80.5.1313 · Cited by 339 · see citing works
Eggstein, M., & Kreutz, F. H. (1966) · Journal of Molecular Medicine · Cited by 293 · see citing works
Isolation and characterization of human plasma lipid transfer proteins.
JAlbers, J., HTollefson, J., HChen, C., & ASteinmetz (1984) · Arteriosclerosis An Official Journal of the American Heart Association Inc · Cited by 287 · see citing works
Turnover of Lipoprotein (a) in Man
Krempler, F., Kostner, G. M., Bolzano, K., & Sandhofer, F. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109813 · Cited by 278 · see citing works
A rapid micromethod for apolipoprotein E phenotyping directly in serum
Havekes, L. M., de Knijff, P., Beisiegel†, U., HAVINGA, J. R., de Smit, M. H., & Klasen, E. C. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38697-1 · Cited by 262 · see citing works
Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment
Gürakar, A. R., Hoeg, J. M., Kostner, G. M., et al. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90041-3 · Cited by 261 · see citing works
Albers, J. J., Taggart, H. M., Applebaum-Bowden, D. M., et al. (1984) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(84)90078-x · Cited by 187 · see citing works
Cheung, M. C., Wolf, A. C., Lum, K. D., et al. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38747-2 · Cited by 172 · see citing works
Treatment of Hyperlipoproteinemia.
(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-5-822_2 · Cited by 155 · see citing works
Albers, J. J., Cabana, V. G., Warnick, G. R., et al. (1975) · Metabolism · doi:10.1016/0026-0495(75)90098-0 · Cited by 151 · see citing works
Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a)
Vessby, B., Kostner, G. M., Lithell, H., & Thomis, J. A. (1982) · Atherosclerosis · doi:10.1016/0021-9150(82)90053-3 · Cited by 145 · see citing works
Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis
Handa, K., Kono, S., Saku, K., et al. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90083-x · Cited by 118 · see citing works
Self-citationGoto, Y., Akanuma, Y., Harano, Y., Yoshiya, H. A. T. A., Itakura, H., Kajiyama, G., KAWADE, M., Shunichi, K. O. G. A., Kuzuya, F., Maruhama, Y., et al. (1986) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.1.73 · Cited by 104 · see citing works
Self-citationMorton, R. E. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38912-3 · Cited by 101 · see citing works
Baker, I. A., Eastham, R. D., Elwood, P. C., Etherington, M. D., O'Brien, J. R., & Sweetnam, P. M. (1982) · Heart · doi:10.1136/hrt.47.5.490 · Cited by 79 · see citing works
NISHIDE, T., Tollefson, J. H., & Albers, J. J. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38377-2 · Cited by 72 · see citing works
Beigel, Y., Fuchs, J., Snir, M., et al. (1991) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1991.tb03729.x · Cited by 63 · see citing works
Niort, G., Bulgarelli, A., Cassader, M., et al. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90135-9 · Cited by 54 · see citing works
Swaim, W. R., & Feders, M. B. (1967) · Clinical Chemistry · doi:10.1093/clinchem/13.11.1026 · Cited by 51 · see citing works
Reduction of serum lipoprotein(a) levels in hyperlipidaemic patients with α-tocopheryl nicotinate
Noma, A., Maeda, S., Okuno, M., et al. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90093-x · Cited by 35 · see citing works
OLSSON, A. G., Orö, L., & Rössner, S. (1974) · Atherosclerosis · doi:10.1016/0021-9150(74)90044-6 · Cited by 31 · see citing works
Proline-rich protein is a glycoprotein and an acute phase reactant
FUNAKOSHI, M., Sasaki, J., & Arakawa, K. (1988) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(88)90342-6 · Cited by 21 · see citing works
Self-citationMailly, F., Davignon, J., & Nestruck, A. C. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42769-5 · Cited by 19 · see citing works
Fletcher, A. P., Alkjærsig, N., Schonfeld, G., et al. (1981) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.1.3.202 · Cited by 9 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813 · see citing works
- Authors
- Matsunaga, A., Handa, K., Mori, T., Moriyama, K., Hidaka, K., Yuki, M., Sasaki, J., & Arakawa, K.
- Affiliations
- Fukuoka University (JP)
- Corresponding author
- Matsunaga, Akira
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 1992-06
- Volume
- 94
- Issue
- 2-3
- Pages
- 241-248
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W1981556855
- Cited by
- 23
- References
- 36
- Citations by year
- 2024: 1 · 2023: 1 · 2018: 1 · 2013: 2
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Atherosclerosis (publishedVersion)
- PubMed (publishedVersion)
- 情報の科学と技術
- Topics
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- primary hypercholesterolemia, lipoprotein(a), fibrinogen, serum lipids, apolipoproteins, apolipoprotein A-II, apolipoprotein B, triglycerides, LDL cholesterol, HDL cholesterol, dosing regimen, statins
- MeSH terms
- Adult, Aged, Apolipoproteins, Apolipoproteins E, Carrier Proteins, Cholesterol, Female, Fibrinogen, Glycoproteins, Humans, Hypercholesterolemia, Lipids, Lipoproteins, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Niceritrol, Phenotype, Triglycerides, Lipoprotein(a), Cholesterol Ester Transfer Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review